Scott Powell | Executive Vice President of Investor Relations |
Cameron Reynolds | President and Chief Executive Officer |
Terig Hughes | Chief Financial Officer |
Tom Butera | Chief Executive Officer, Volition Veterinary Diagnostics Development |
Ross Osborn | Cantor Fitzgerald |
Bruce Jackson | The Benchmark Company |
Nathan Weinstein | Aegis Capital |
Michael Okunewitch | Maxim |
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited's Fourth Quarter and Full Year 2021 Earnings Conference Call. [Operator Instructions] This conference is being recorded today, March 31, 2022. I would now like to turn the conference call over to Scott Powell, Executive Vice President of Investor Relations.